Nabriva Therapeutics plc - stock earnings
Stock symbol NBRV is outdated, potentially delisted? Maybe it is available on other exchange?
NBRV Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -22.8 million USD | 10.6 million USD |
| 2022Q3 | -11.5 million USD | 9.2 million USD |
| 2022Q2 | -11.1 million USD | 9.2 million USD |
| 2022Q1 | -11.8 million USD | 8.0 million USD |
| 2021Q4 | -13.1 million USD | 9.3 million USD |
| 2021Q3 | -10.7 million USD | 8.9 million USD |
| 2021Q2 | -11.8 million USD | 8.2 million USD |
| 2021Q1 | -14.0 million USD | 2.5 million USD |
| 2020Q4 | -17.8 million USD | 2.5 million USD |
NBRV Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -57.2 million USD | 36.9 million USD |
| 2021 | -49.5 million USD | 28.9 million USD |
| 2020 | -69.5 million USD | 5.0 million USD |
| 2019 | -82.8 million USD | 9.5 million USD |
| 2018 | -114.8 million USD | 9.7 million USD |
| 2017 | -74.4 million USD | 5.3 million USD |
NBRV
Price: $1.42
52 week price:
Earnings Per Share: -8.76 USD
P/E Ratio: -0.62
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 23200
Ebitda: -20.2 millionMarket Capitalization: 6.0 million